• slidebg1
  • slidebg1
  • slidebg1
  • slidebg1
  • slidebg1
  • 23
    06/17
    NEWS
    Chiesi Farmaceutici completes the acquisition of European Marketing Rights to...
    Parma (Italy) – June 23, 2017 – Chiesi Farmaceutici S.p.A. (Chiesi Group), an international research-focused...
  • PRESS RELEASE
    Trimbow® is the first triple combination in a single inhaler for the treatment...
    Chiesi is the first pharmaceutical company to have demonstrated with randomized clinical trials, two of which published in The...